FDA Clinical Trials - A Timeline for Cancer versus Diseases Presently Targeted by Breathtec
Owlstone Ltd
Study Type: Interventional Study Design: Intervention Model: Single Group Assignment Masking: Open Label Primary Purpose: Diagnostic Official Title: Lung Cancer Indicator Detection
Estimated Enrollment: 520 Study Start Date: October 2015 Estimated Study Completion Date: August 2020 Estimated Primary Completion Date: August 2019 (Final data collection date for primary outcome measure)
Study Type: Observational Study Design: Observational Model: Case-Only Time Perspective: Prospective Official Title: Infection Detection by Breath Analysis
Estimated Enrollment: 500 Study Start Date: November 2016 Estimated Study Completion Date: November 2018 Estimated Primary Completion Date: November 2017 (Final data collection date for primary outcome measure)